CAMP4 THERAPEUTICS CORPORATION (CAMP) stock news · rev $3.5M
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
This CAMP news page leads with what CAMP4 THERAPEUTICS CORPORATION filed — not a scraped headline mill.
No cached 8-K sentence for CAMP yet. We will not pad this page with generic market recap.
Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CAMP stock page; for the tape open the quote page.
CAMP stock news FAQ
What are CAMP's latest revenue and net income?
Latest cached CAMP4 THERAPEUTICS CORPORATION (CAMP) revenue for Dec 31, 2025 was $3.5M. Net income was -$80.4M. Statements: https://lician.com/financials/camp
How did CAMP revenue change from the prior cached period?
Cached CAMP4 THERAPEUTICS CORPORATION (CAMP) revenue was up 436.5% from $652.0K (Dec 31, 2024) to $3.5M (Dec 31, 2025). Statements: https://lician.com/financials/camp
What is CAMP's market cap?
CAMP4 THERAPEUTICS CORPORATION (CAMP) market cap is $215.0M on the latest cached fundamentals snapshot.
What kind of company is CAMP?
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
Where is CAMP stock news listed?
Cached stock news for CAMP4 THERAPEUTICS CORPORATION (CAMP) is listed at https://lician.com/news/camp. Filings: https://lician.com/sec/camp
Not investment advice.